Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Written on 11/04/2025

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.
Read full article